Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strainsLiu, L.; Coller, J.; Watkins, L.; Somogyi, A.; Hutchinson, M.
2012Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patientsColler, J.; Michalakas, J.; James, H.; Farquharson, A.; Colvill, J.; White, J.; Somogyi, A.
2012ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsBarratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2011Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samplesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2014Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesMd Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2018CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantationHu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.
2015Pharmacogenetics of opioid responseSomogyi, A.; Coller, J.; Barratt, D.
2012Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceWu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M.
2012Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsGelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.